Jane Henderson, Chief Financial Officer at Apogee Therapeutics, Inc. (APGE), sold 6,000 shares at $48.26 ($290K) on 2024-08-23, disclosed to the SEC on 2024-08-23.
Open-market sale of $290k APGE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |